Autoimmune Disease Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The global autoimmune disease diagnostics market size was valued at USD 3.3 billion in the year 2015 and is estimated to reach a value of USD 5.0 billion by 2027, growing with a CAGR of 4%.

Autoimmune disease is an abnormal immune response in the body that produces antibodies that attack its own cells and tissues, making them worse and destroying healthy tissues. There are nearly 80 types of autoimmune diseases worldwide, including systemic lupus erythematosus or rheumatoid arthritis. Autoimmune diseases affect up to 50 million Americans, 75% of which are women, according to estimates by the American Association of Autoimmune Related Diseases (AARDA). Tests used to diagnose autoimmune disorders include autoantibody tests, antinuclear antibody tests, complete blood count, C-reactive protein, and erythrocyte sedimentation rate.

Market Segments

By Product

• Consumables & Assay Kits
• Instruments

By Test Type

• Routine Laboratory Tests
• Inflammatory Markers
• Autoantibodies & Immunologic Test
• Other Tests

By Disease

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Sjögren’s Syndrome
• Thyroiditis
• Scleroderma
• Other Diseases

Key Market Players:

The prominent players operating in autoimmune disease diagnosis market include Thermo Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), HYCOR Biomedical (US), EUROIMMUN AG (Germany), Oncimmune (UK), HTG Molecular Diagnostics (US), Seramun Diagnostica GmbH (Germany), Exagen Inc. (US), Cambridge Life Sciences Limited (UK), A. Menarini Diagnostics s.r.l (Italy), ORGENTEC Diagnostika (Germany), KRONUS (US), and AESKU GROUP GMBH & CO. KG (Germany).

Scope of the Report

The research study analyzes the global Autoimmune Disease Diagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Autoimmune Disease Diagnostics Market Report

1. What was the Autoimmune Disease Diagnostics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027). 2. What will be the CAGR of the Autoimmune Disease Diagnostics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Autoimmune Disease Diagnostics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.